R.G. Niederhoffer Capital Management’s Pfizer PFE Stock Holding History

R.G. Niederhoffer Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,861	Closed	-$512K	–	38
2018 Q2	$512K	Buy	+14,861	New	+$508K	2.94%	16
2017 Q4	–	Sell	-13,280	Closed	-$449K	–	21
2017 Q3	$449K	Buy	+13,280	New	+$427K	2.89%	16
2017 Q2	–	Sell	-9,802	Closed	-$319K	–	30
2017 Q1	$319K	Buy	+9,802	New	+$309K	2.06%	17
2014 Q2	–	Sell	-27,088	Closed	-$826K	–	39
2014 Q1	$826K	Buy	+27,088	New	+$808K	3.37%	16

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

R.G. Niederhoffer Capital Management's PFE Position: Q3 2018 in Review

R.G. Niederhoffer Capital Management sold out of Pfizer (PFE) in Q3 2018, closing a stake of 14,861 shares — an estimated $512K sold.

R.G. Niederhoffer Capital Management first reported a position in PFE in Q1 2014 and held it in 4 quarters. The position peaked at $826K in Q1 2014. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

R.G. Niederhoffer Capital Management reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
R.G. Niederhoffer Capital Management sold 14,861 Pfizer shares in Q3 2018, an estimated $512K.
R.G. Niederhoffer Capital Management first reported a position in Pfizer in Q1 2014 and held it in 4 quarters.
R.G. Niederhoffer Capital Management's Pfizer position peaked at $826K in Q1 2014.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q3 2018, filed 31 Oct 2018.